Artikel mit Open-Access-Mandaten - Melissa ConradWeitere Informationen
Nicht verfügbar: 2
Antimalarial drug resistance in Africa: the calm before the storm?
MD Conrad, PJ Rosenthal
The Lancet Infectious Diseases 19 (10), e338-e351, 2019
Mandate: US National Institutes of Health
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa
PJ Rosenthal, V Asua, MD Conrad
Nature Reviews Microbiology, 1-12, 2024
Mandate: Bill & Melinda Gates Foundation, European & Developing Countries Clinical …
Verfügbar: 58
Absence of Putative Artemisinin Resistance Mutations Among Plasmodium falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study
SM Taylor, CM Parobek, DK DeConti, K Kayentao, SO Coulibaly, ...
The Journal of infectious diseases 211 (5), 680-688, 2015
Mandate: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women
RM Brotman, LL Bradford, M Conrad, P Gajer, K Ault, L Peralta, LJ Forney, ...
Sexually transmitted diseases 39 (10), 807-812, 2012
Mandate: US National Institutes of Health
Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda
V Asua, MD Conrad, O Aydemir, M Duvalsaint, J Legac, E Duarte, ...
The Journal of infectious diseases 223 (6), 985-994, 2021
Mandate: US National Institutes of Health
Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children
MD Conrad, V Bigira, J Kapisi, M Muhindo, MR Kamya, DV Havlir, ...
PloS one 9 (8), e105690, 2014
Mandate: US National Institutes of Health
Extensive Genetic Diversity, Unique Population Structure and Evidence of Genetic Exchange in the Sexually Transmitted Parasite Trichomonas vaginalis
MD Conrad, AW Gorman, JA Schillinger, PL Fiori, R Arroyo, N Malla, ...
PLoS Neglected Tropical Diseases 6 (3), e1573, 2012
Mandate: US National Institutes of Health
Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in …
MD Conrad, N LeClair, E Arinaitwe, H Wanzira, A Kakuru, V Bigira, ...
The Journal of infectious diseases 210 (3), 344-353, 2014
Mandate: US National Institutes of Health, Doris Duke Charitable Foundation
Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study
C Andolina, JC Rek, J Briggs, J Okoth, A Musiime, J Ramjith, N Teyssier, ...
The Lancet Infectious Diseases 21 (11), 1568-1578, 2021
Mandate: Bill & Melinda Gates Foundation, US National Institutes of Health …
Artesunate/amodiaquine versus artemether/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial
A Yeka, R Kigozi, MD Conrad, M Lugemwa, P Okui, C Katureebe, K Belay, ...
The Journal of infectious diseases 213 (7), 1134-1142, 2016
Mandate: Bill & Melinda Gates Foundation, US National Institutes of Health
The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC
R Verity, O Aydemir, NF Brazeau, OJ Watson, NJ Hathaway, ...
Nature communications 11 (1), 2107, 2020
Mandate: US National Institutes of Health, UK Medical Research Council
Impact of vector control interventions on malaria transmission intensity, outdoor vector biting rates and Anopheles mosquito species composition in Tororo, Uganda
AK Musiime, DL Smith, M Kilama, J Rek, E Arinaitwe, JI Nankabirwa, ...
Malaria journal 18, 1-9, 2019
Mandate: US National Institutes of Health
Evolution of partial resistance to artemisinins in malaria parasites in Uganda
MD Conrad, V Asua, S Garg, D Giesbrecht, K Niaré, S Smith, ...
New England Journal of Medicine 389 (8), 722-732, 2023
Mandate: US National Institutes of Health
Lack of artemisinin resistance in Plasmodium falciparum in Uganda based on parasitological and molecular assays
RA Cooper, MD Conrad, QD Watson, SJ Huezo, H Ninsiima, ...
Antimicrobial agents and chemotherapy 59 (8), 5061-5064, 2015
Mandate: US National Institutes of Health
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda
GW Mbogo, S Nankoberanyi, S Tukwasibwe, FN Baliraine, SL Nsobya, ...
The American journal of tropical medicine and hygiene 91 (1), 54, 2014
Mandate: US National Institutes of Health, Doris Duke Charitable Foundation
Microsatellite polymorphism in the sexually transmitted human pathogen Trichomonas vaginalis indicates a genetically diverse parasite
M Conrad, Z Zubacova, LA Dunn, J Upcroft, SA Sullivan, J Tachezy, ...
Molecular and biochemical parasitology 175 (1), 30-38, 2011
Mandate: US National Institutes of Health
Synteny and candidate gene prediction using an anchored linkage map of Astyanax mexicanus
JB Gross, M Protas, M Conrad, PE Scheid, O Vidal, WR Jeffery, ...
Proceedings of the National Academy of Sciences 105 (51), 20106-20111, 2008
Mandate: US National Institutes of Health
Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from Ugandan children
P Tumwebaze, MD Conrad, A Walakira, N LeClair, O Byaruhanga, ...
Antimicrobial agents and chemotherapy 59 (6), 3018-3030, 2015
Mandate: US National Institutes of Health, Doris Duke Charitable Foundation
Changing antimalarial drug sensitivities in Uganda
SA Rasmussen, FG Ceja, MD Conrad, PK Tumwebaze, O Byaruhanga, ...
Antimicrobial agents and chemotherapy 61 (12), 10.1128/aac. 01516-17, 2017
Mandate: US National Institutes of Health
Getting trichy: tools and approaches to interrogating Trichomonas vaginalis in a post-genome world
MD Conrad, M Bradic, SD Warring, AW Gorman, JM Carlton
Trends in parasitology 29 (1), 17-25, 2013
Mandate: US National Institutes of Health
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt